Donate
Australian & New Zealand Childrens Haematology/Oncology Group

ANZCHOG Children’s Cancer Clinical Trials Repository

Study Title
A pilot and surgical study of larotrectinib for treatment of children with newly-diagnosed high-grade glioma with NTRK fusion
Protocol ID
CONNECT1903
Disease (Sub Disease)
Brain and Spinal Tumours (High Grade Gliomas)
Diagnosis Stage
New diagnosis
Location
NSW, QLD, WA
Sponsor
Australian and New Zealand Children's Haematology Oncology Group
Nationwide Children's Hospital
Trial Status
Open
Sites
Perth Children's Hospital
Sydney Children's Hospital
Queensland Children's Hospital
Study Type
Treatment
Phase
Pilot
Age Eligibility
up to 21 years
International registry ID's
NCT04655404
Back to Registry
Study Title A pilot and surgical study of larotrectinib for treatment of children with newly-diagnosed high-grade glioma with NTRK fusion
Protocol ID CONNECT1903
Disease (Sub Disease) Brain and Spinal Tumours (High Grade Gliomas)
Diagnosis Stage New diagnosis
Location NSW / QLD / WA
Sponsor Australian and New Zealand Children's Haematology Oncology Group/ Nationwide Children's Hospital
Links https://clinicaltrials.gov/ct2/show/NCT04655404
Trial Status Open
Trial Open Date 08/04/2021
Sites Perth Children's Hospital / Sydney Children's Hospital / Queensland Children's Hospital
Study Type Treatment
Phase Pilot
Age Eligibility up to 21 years
International registry ID's NCT04655404